Si, Si
University of Washington · Institute for Health Metrics and Evaluation
5 papers on CoChatORCID 0000-0002-2406-7221
Most cited papers
- Verified
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet
Global Health and EpidemiologyInsurance, Mortality, Demography, Risk Management
Cited by 13,867
- Verified
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet
Insurance, Mortality, Demography, Risk ManagementGlobal Health and Epidemiology
Cited by 8,600
- Verified
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet
Cardiovascular Health and Risk FactorsOccupational Health and Global Justice
Cited by 4,943
- Verified
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17
Deshpande, A., Miller-Petrie, M. K., Lindstedt, P. A., Baumann, M. M., Johnson, K. B., Blacker, B. F., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahpour, I., et al. (2020) · The Lancet Global Health
Child Nutrition and Water AccessWater Resource Management and Quality
Cited by 187
- Verified
Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes
Chin, K. L., Ofori-Asenso, R., Si, S., Hird, T. R., Magliano, D. J., Zoungas, S., & Liew, D. (2019) · Scientific Reports
Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free